Note: Bioq Pharma's revenues are gauged from an analysis of company filings.
Bioq Pharma's Income Statement (based on Industry Averages)
Bioq Pharma P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
Bioq Pharma has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
January 10, 2020
15
25%
$19 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Bioq Pharma is developing and marketing.
Bioq Pharma doesn't have any recent trademark applications, indicating Bioq Pharma is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
BIOQ PHARMA Pharmaceutical and veterinary preparations for treatment of medical disorders treatable by parenteral infusion therapy, namely, pain, cancer, infectious diseases, bacterial diseases, autoimmune diseases, cardiovascular diseases, fungal diseases, and metabolic diseases, and for induction and maintenance of anesthesia; Sterile preparations for medical purposes in clinical treatment for treating pain, cancer, infectious diseases, bacterial diseases, autoimmune diseases, cardiovascular diseases, fungal diseases and metabolic diseases, and for administering anesthesia; Medicinal preparations for pharmaceutical purposes for treating pain, cancer, infectious diseases, bacterial diseases, autoimmune diseases, cardiovascular diseases, fungal diseases and metabolic diseases, and for administering anesthesia; Drug delivery agents in the form of pharmaceutical infusion pumps that facilitate the delivery of pharmaceutical preparations; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations
06/10/2020
SEDA-Q Pharmaceutical and veterinary preparations for the treatment of medical disorders treatable by parenteral infusion therapy, namely, pain, cancer, infectious diseases, bacterial diseases, autoimmune diseases, cardiovascular diseases, fungal diseases, and metabolic diseases and for induction and maintenance of anesthesia; Sterile preparations for medical purposes in clinical treatment for treating pain, cancer, infectious diseases, bacterial diseases, autoimmune diseases, cardiovascular diseases, fungal diseases and metabolic diseases and for induction and maintenance of anesthesia; Medicinal preparations for pharmaceutical purposes for treating pain, cancer, infectious diseases, bacterial diseases, autoimmune diseases, cardiovascular diseases, fungal diseases and metabolic diseases and for induction and maintenance of anesthesia; Drug delivery agents in the form of pharmaceutical infusion pumps that facilitate the delivery of pharmaceutical preparations; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations
05/29/2020
INVENIOUS Surgical, medical, dental and veterinary apparatus and instruments for performing parenteral infusions in the field of medical and surgical procedures; Parenteral infusion pumps and dispensers; Medical infusion pumps
03/26/2019
See all trademarks and details in the Full Report.
Latest News Releases
Date
Event
May 16, 2017
BioQ Pharma to Present at the UBS Global Healthcare Conference
Apr 04, 2017
BioQ Pharma and Lunatus Add a Third Infusion Pharmaceutical to Commercial Agreement Covering Arabian Gulf Area and Middle East
Mar 30, 2017
BioQ Pharma to Present at the 16th Annual Needham Healthcare Conference
Mar 17, 2017
BioQ Pharma to Present at 27th Annual Oppenheimer Healthcare Conference
Mar 14, 2017
BioQ Pharma Receives Australian Regulatory Approval for Ropivacaine ReadyFusOR
Market Share of Bioq Pharma's Largest Competitors
A competitive analysis shows these companies are in the same general field as Bioq Pharma, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Bioq Pharma.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Bioq Pharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.